Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma

We explored the hypothesis that sorafenib may improve the effect of transarterial chemoembolization (TACE) in patients with recurrent hepatocellular carcinoma (HCC) and that longer sorafenib duration was associated with additional survival benefits. In this retrospective, nested case-controlled stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Wan, Xuying, Zhai, Xiaofeng, Yan, Zhenlin, Yang, Pinghua, Li, Jun, Wu, Dong, Wang, Kui, Xia, Yong, Shen, Feng
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Clinical Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347807/
https://ncbi.nlm.nih.gov/pubmed/27566566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11514
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky